share_log

POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

POS AM:修改註冊聲明表
美股SEC公告 ·  10/11 14:39

Moomoo AI 已提取核心訊息

Aclarion, Inc. has entered into an Equity Line Purchase Agreement with White Lion Capital LLC, which was established on October 9, 2023. Under this agreement, Aclarion has the discretion to sell up to $10 million worth of shares to White Lion, subject to specified terms and conditions. As part of the ongoing financial arrangement, Aclarion has already sold 1,800,000 shares of common stock to White Lion as of August 2024. Additionally, White Lion is covered by a Registration Statement filed on October 11, 2024, for the resale of up to 1,450,000 shares of Aclarion's common stock. The capital raised from these transactions is intended for general corporate purposes, including working capital. Aclarion, which trades under the ticker 'ACON' on the Nasdaq Capital Market, has faced compliance issues with Nasdaq's minimum bid price and stockholders' equity requirements, receiving deficiency letters. In response, Aclarion is planning a reverse stock split to meet the Bid Price Requirement and has appealed the delisting notices, actively seeking solutions to regain compliance with Nasdaq's standards.
Aclarion, Inc. has entered into an Equity Line Purchase Agreement with White Lion Capital LLC, which was established on October 9, 2023. Under this agreement, Aclarion has the discretion to sell up to $10 million worth of shares to White Lion, subject to specified terms and conditions. As part of the ongoing financial arrangement, Aclarion has already sold 1,800,000 shares of common stock to White Lion as of August 2024. Additionally, White Lion is covered by a Registration Statement filed on October 11, 2024, for the resale of up to 1,450,000 shares of Aclarion's common stock. The capital raised from these transactions is intended for general corporate purposes, including working capital. Aclarion, which trades under the ticker 'ACON' on the Nasdaq Capital Market, has faced compliance issues with Nasdaq's minimum bid price and stockholders' equity requirements, receiving deficiency letters. In response, Aclarion is planning a reverse stock split to meet the Bid Price Requirement and has appealed the delisting notices, actively seeking solutions to regain compliance with Nasdaq's standards.
Aclarion, Inc.已經與White Lion Capital LLC簽訂了一項股權質押購買協議,該協議於2023年10月9日設立。根據該協議,Aclarion有權自行決定向White Lion出售最多1000萬美元的股份,但需符合特定條款和條件。作爲持續的財務安排的一部分,截至2024年8月,Aclarion已經向White Lion出售了180萬股普通股。此外,White Lion在2024年10月11日提交了一份登記聲明,用於轉售最多145萬股Aclarion普通股。從這些交易中籌集的資金用於一般企業用途,包括營運資金。Aclarion在納斯達克資本市場上的交易代號爲'ACON',已面臨納斯達克最低買盤價格和股東權益要求的合規問題,收到了違規通知。作爲回應,Aclarion計劃進行股權合併以滿足買盤價格要求,並上訴撤銷上市通知,積極尋找方案以恢復符合納斯達克的標準。
Aclarion, Inc.已經與White Lion Capital LLC簽訂了一項股權質押購買協議,該協議於2023年10月9日設立。根據該協議,Aclarion有權自行決定向White Lion出售最多1000萬美元的股份,但需符合特定條款和條件。作爲持續的財務安排的一部分,截至2024年8月,Aclarion已經向White Lion出售了180萬股普通股。此外,White Lion在2024年10月11日提交了一份登記聲明,用於轉售最多145萬股Aclarion普通股。從這些交易中籌集的資金用於一般企業用途,包括營運資金。Aclarion在納斯達克資本市場上的交易代號爲'ACON',已面臨納斯達克最低買盤價格和股東權益要求的合規問題,收到了違規通知。作爲回應,Aclarion計劃進行股權合併以滿足買盤價格要求,並上訴撤銷上市通知,積極尋找方案以恢復符合納斯達克的標準。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息